Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advances

Trends in Endocrinology and Metabolism

Volumn 18, Issue 4, 2007, Pages 167-174

  Storr, Helen L ^a   Chan, Li F ^a   Grossman, Ashley B ^a   Savage, Martin O ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CYTOTOXIC AGENT; MITOTANE;

ADOLESCENCE; ADRENAL CORTEX TUMOR; ADRENAL HYPERPLASIA; ADRENALECTOMY; ALBRIGHT SYNDROME; BODY COMPOSITION; CHILD CARE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ECTOPIC CORTICOTROPIN PRODUCTION; GENE MUTATION; HUMAN; INCIDENCE; PRIORITY JOURNAL; PUBERTY; REVIEW; TREATMENT PLANNING;

ADOLESCENT; ADRENAL GLANDS; ADULT; CHILD; CUSHING SYNDROME; HUMANS;

EID: 34247371463     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2007.03.005     Document Type: Review

References (91)

1. Magiakou M.A., and Chrousos G.P. Cushing's syndrome in children and adolescents: Current diagnostic and therapeutic strategies. J. Endocrinol. Invest. 25 (2002) 181-194
2. Savage M.O., and Besser G.M. Cushing's disease in childhood. Trends Endocrinol. Metab. 7 (1996) 213-216
3. Lumbroso S., et al. Activating Gsα mutations: analysis of 113 patients with signs of McCune-Albright syndrome - a European collaborative study. J. Clin. Endocrinol. Metab. 89 (2004) 2107-2113
4. Yoshimoto M., et al. A case of neonatal McCune-Albright syndrome with Cushing syndrome and hyperthyroidism. Acta Paediatr. Scand. 80 (1991) 984-987
5. Kirk J.M., et al. Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J. Pediatr. 134 (1999) 789-792
6. Boston B.A., et al. Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushing's syndrome and nodular adrenal hyperplasia. J. Clin. Endocrinol. Metab. 79 (1994) 890-893
7. Mayer S.K., et al. Childhood adrenocortical tumours : case series and reevaluation of prognosis - a 24-year experience. J. Pediatr. Surg. 32 (1997) 911-915
8. Stratakis C. Cushing syndrome and Addison disease. In: Hughes I.A., and Clark A.J.L. (Eds). Adrenal Disease in Childhood (2000), Karger
9. Ribeiro R.C., et al. An inherited p53 mutation that contributes in a tissue-specific manner to paediatric adrenal cortical carcinoma. Proc. Natl. Acad. Sci. USA 98 (2001) 9330-9335
10. Michalkiewicz E., et al. Clinical and outcome characteristics of children with adrenocortical tumours: a report from the International Paediatric Adrenocortical Tumour Registry. J. Clin. Oncol. 22 (2004) 838-845
11. Latronico A.C., et al. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumour suppressor protein in children and adults with sporadic adrenocortical tumours. J. Clin. Endocrinol. Metab. 86 (2001) 4970-4973
12. Stratakis C.A. Genetics of adrenocortical tumours: gatekeepers, landscapers and conductors in symphony. Trends Endocrinol. Metab. 14 (2004) 404-410
13. Sbragia L., et al. Adrenocortical tumours in Brazilian children. Arch. Pathol. Lab. Med. 129 (2005) 1127-1131
14. Isidori A.M., et al. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management and long-term follow-up. J. Clin. Endocrinol. Metab. 91 (2006) 371-377
15. Ilias I., et al. Cushing's syndrome due to ectopic corticotropin secretion: twenty years experience at the National Institutes of Health. J. Clin. Endocrinol. Metab. 90 (2005) 4955-4962
16. Salgado L.R., et al. Ectopic ACTH syndrome: our experience with 25 cases. Eur. J. Endocrinol. 155 (2006) 725-733
17. Hannah J., et al. Oncocytic carcinoid of the kidney associated with periodic Cushing's syndrome. Cancer 61 (1988) 2136-2140
18. Amano S., et al. Ectopic ACTH-MSH producing carcinoid tumour with multiple endocrine hyperplasia in a child. Acta Pathol. Jpn 28 (1978) 721-730
19. Hsaio J.C., et al. Ectopic ACTH syndrome due to clear cell sarcoma of the kidney. Child Nephrol. Urol. 11 (1991) 103-106
20. Hinnie J., et al. Cushing's syndrome in a 16 year old girl due to ectopic ACTH precursor production from a pancreatic tumour. Clin. Endocrinol. (Oxf.) 53 (2000) 539-541
21. Thomas R.J., et al. Wilms' tumor presenting as Cushing's syndrome. Pediatr. Surg. Int. 13 (1998) 293-294
22. Espinassa-Holder M., et al. Paraneoplastic Cushing's syndrome due to adrenal neuroblastoma. Med. Pediatr. Oncol. 34 (2000) 231-233
23. Stratakis C.A., et al. Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann. Intern. Med. 131 (1999) 585-591
24. Stergiopoulos S.G., et al. Human tumors associated with Carney complex and germline PRKAR1A mutations: a protein kinase A disease!. FEBS Lett. 546 (2003) 59-64
25. Stratakis C.A., et al. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J. Clin. Endocrinol. Metab. 86 (2001) 4041-4046
26. Shenoy B.V., et al. Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing's syndrome. Am. J. Surg. Pathol. 8 (1984) 335-344
27. Carney J.A., et al. The complex of myxomas, spotty pigmentation and endocrine overactivity. Medicine (Baltimore) 64 (1985) 270-283
28. Storr H.L., et al. Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia. Clin. Endocrinol. (Oxf.) 61 (2004) 553-559
29. Gunther D.F., et al. Cyclical Cushing's syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease or a new entity?. J. Clin. Endocrinol. Metab. 89 (2004) 3173-3182
30. Sandrini F., and Stratakis C.A. Clinical and molecular genetics of Carney complex. Mol. Genet. Metab. 78 (2003) 83-92
31. Groussin L., et al. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am J Hum Genet. 71 (2002) 1433-1442
32. Groussin L., et al. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. J. Clin. Endocrinol. Metab. 87 (2002) 4324-4329
33. Stratakis C.A., and Kirschner M. Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing's syndrome. Horm. Metab. Res. 30 (1998) 456-463
34. Carney J., and Young W.F. Primary pigmented nodular adrenocortical disease and its associated conditions. Endocrinologist 2 (1992) 6-21
35. Stratakis C.A., and Ball D.W. A concise genetic and clinical guide to multiple endocrine neoplasia and related syndromes. J. Pediatr. Endocrinol. Metab. 13 (2000) 457-465
36. Magiakou M.A., et al. Cushing's syndrome in children and adolescents. Presentation, diagnosis and therapy. N. Engl. J. Med. 331 (1994) 629-636
37. Weber A., et al. Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome. Clin. Endocrinol. (Oxf.) 43 (1995) 19-28
38. Fahlbusch R., et al. Neurosurgical management of Cushing's disease in children. In: Savage M.O., Bourguignon J.P., and Grossman A.B. (Eds). Frontiers of Paediatr Neuroendocrinol (1994), Blackwell Scientific Publications, Oxford 68-72
39. Storr H.L., et al. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease. Eur. J. Endocrinol. 152 (2005) 825-833
40. Khadilkar V.V., et al. Cushing's disease in an 11-month-old child. Indian Pediatr. 41 (2004) 274-276
41. Damiani D., et al. Pituitary macroadenoma and Cushing's disease in paediatric patients: patient report and review of the literature. J. Ped. Endocrinol. Metab. 11 (1998) 665-669
42. Stratakis C.A., et al. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab. 85 (2000) 4776-4780
43. Besser G.M., and Trainer P.J. Cushing's syndrome. In: Besser G.M., and Thorner M.O. (Eds). Comp Clin Endocrinol. 3rd edn (2002), Mosby 193-202
44. Leinung M.C., et al. Long-term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in childhood. J. Clin. Endocrinol. Metab. 80 (1995) 2475-2479
45. Devoe D.J., et al. Long term outcome in children and adolescents after trans-sphenoidal surgery for Cushing's disease. J. Clin. Endocrinol. Metab. 82 (1997) 3196-3202
46. Storr H.L., et al. Pre-pubertal Cushing's is more common in males, but there is no increase in severity at diagnosis. J. Clin. Endocrinol. Metab. 89 (2004) 3818-3820
47. Greening J.E., et al. Linear growth and body mass index in paediatric patients with Cushing's disease or simple obesity. J. Endocrinol. Invest. 29 (2006) 885-887
48. Peters, C.J. et al. Factors influencing skeletal maturation at diagnosis of paediatric Cushing's disease. Horm. Res. (in press)
49. Dupuis, C. et al. Abnormal puberty in paediatric Cushing's disease; relationships with adrenal androgens, sex hormone binding globulin and gonadotrophin concentrations. Clin. Endocrinol. (Oxf.) (in press)
50. Hauffa B.P., et al. Dissociation between plasma adrenal androgens and cortisol in Cushing's disease and ectopic ACTH-producing tumour: elation to adrenarche. Lancet 1 (1984) 1373-1376
51. Newell-Price J., et al. The diagnosis and differential diagnosis of Cushing's and pseudo-Cushing's syndrome. Endocr. Rev. 19 (1998) 647-672
52. Arnaldi G., et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88 (2003) 5593-5602
53. Peters C.J., et al. The role of corticotrophin-releasing hormone in the diagnosis of Cushing's syndrome. Eur. J. Endocrinol. 155 (2006) S93-S98
54. Dias R., et al. The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome. Horm. Res. 65 (2006) 159-162
55. Mellinger R., and Smith R.W. Studies of the adrenal hyperfunction in 2 patients with atypical Cushing's syndrome. J. Clin. Endocrinol. Metab. 16 (1956) 350-366
56. Cheung P.S., and Thompson N.W. Carney's complex of primary pigmented nodular adrenocortical disease and pigmentous and myxomatous lesions. Surg. Gynecol. Obstet. 168 (1989) 413-416
57. Akbas H., et al. Surgical treatment of left-atrial myxoma in Carney's complex. Thor. Cardiovasc. Surg. 45 (1997) 148-150
58. Carney J., et al. Dominant inheritance of the complex of myxomas, spotty skin pigmentation and endocrine overreactivity. Mayo Clin. Proc. 61 (1986) 165-172
59. Stratakis C., et al. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 11. J. Clin. Invest. 97 (1996) 699-705
60. Kirschner L.S., et al. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum. Mol. Genet. 9 (2000) 3037-3046
61. Hanson J.A., et al. Magnetic resonance imaging of adrenocortical adenomas in children: correlation with computed tomography and ultrasound. Pediatr. Radiol. 26 (1996) 794-799
62. Doppman J.L. Problems in endocrinologic imaging. Endocrinol. Metab. Clin. North Am. 26 (1997) 973-991
63. Doppman J.L., et al. Cushing syndrome due to primary pigmented nodular adrenocortical disease: Findings at CT and MR imaging. Radiology 172 (1989) 415-420
64. Rockall A.G., et al. CT and MR imaging of the adrenal glands in ACTH-independent Cushing syndrome. Radiographics 24 (2004) 435-452
65. Oldfield E.H., et al. Petrosal sinus sampling with corticotropin-releasing hormone to distinguish Cushing's disease from pseudo-Cushing's states or normal physiology. N. Engl. J. Med. 325 (1991) 897-905
66. Lienhardt A., et al. Relative contributions of inferior petrosal sinus sampling and pituitary imaging in the investigation of children and adolescents with ACTH-dependent Cushing's syndrome. J. Clin. Endocrinol. Metab. 86 (2001) 5711-5714
67. Batista D., et al. An assessment of petrosal sinus sampling for localisation of pituitary microadenomas in children with Cushing disease. J. Clin. Endocrinol. Metab. 91 (2006) 221-224
68. Stratakis C. Cushing's syndrome and Addison disease. Endocrine Dev. 2 (2000) 150-173
69. Hopwood N.J., and Kenny F.M. Incidence of Nelson's syndrome after adrenalectomy for Cushing's disease in children: results of a nationwide survey. Am. J. Dis. Child. 131 (1977) 1353-1356
70. McArthur R.G., et al. Childhood Cushing disease: results of bilateral adrenalectomy. J. Pediatr. 95 (1979) 214-219
71. Greening J.E., et al. Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's syndrome. Horm. Res. 64 (2005) 140-143
72. Massoud A.F., et al. Transsphenoidal surgery for pituitary tumours. Arch. Dis. Child. 76 (1997) 398-404
73. Knappe U.J., and Ludecke D.K. Transnasal microsurgery in children and adolescents with Cushing's disease. Neurosurgery 39 (1996) 484-493
74. Kanter A.S., et al. Single-center experience with paediatric Cushing's disease. J. Neurosurg. 103 Suppl. 5 (2005) 413-420
75. Joshi S.M., et al. Cushing's disease in children and adolescents: 20 years of experience in a single neurosurgical centre. Neurosurgery 57 (2005) 281-285
76. Trainer P.J., et al. Transsphenoidal resection in Cushing's disease : undetectable serum cortisol as the definition of successful treatment. Clin. Endocrinol. (Oxf.) 38 (1993) 73-78
77. Linglart A., and Visot A. Cushing's disease in children and adolescents. Neurochirurgie 48 (2002) 271-280
78. Styne D.M., et al. Treatment of Cushing's syndrome in childhood and adolescence by transsphenoidal microadenomectomy. N. Engl. J. Med. 310 (1984) 889-893
79. Jennings A.S., et al. Results of treating childhood Cushing's disease with pituitary irradiation. N. Engl. J. Med. 297 (1977) 957-962
80. Thoren M., et al. Treatment of Cushing's disease in childhood and adolescence by stereotactic pituitary irradiation. Acta Paediatr. Scand. 75 (1986) 388-395
81. Storr H.L., et al. Clinical and endocrine responses to pituitary radiotherapy in paediatric Cushing's disease. J. Clin. Endocrinol. Metab. 88 (2003) 34-37
82. Plowman P.N. Pituitary radiotherapy: techniques and potential complications. In: Sheaves R., Jenkins P.J., and Wass J.A.H. (Eds). Clinical Endocrine Oncology (1997), Blackwell Scientific Publications, Oxford 185-188
83. Chan, L. et al. Long-term anterior pituitary function in patients with paediatric Cushing's disease treated with pituitary radiotherapy. Eur. J. Endocrinol. (in press)
84. Nicholl R.M., et al. Acceleration of pubertal development following pituitary radiotherapy for Cushing's disease. Clin. Oncol. 5 (1993) 393-394
85. Lebrethon M.-C., et al. Linear growth and final height after treatment of Cushing's disease in childhood. J. Clin. Endocrinol. Metab. 85 (2000) 3262-3265
86. Magiakou M.A., et al. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure. J. Clin. Endocrinol. Metab. 78 (1994) 131-137
87. Magiakou M.A., et al. Final stature in patients with endogenous Cushing's syndrome. J. Clin. Endocrinol. Metab. 79 (1994) 1082-1085
88. Davies J.H., et al. Final adult height and body mass index after cure of paediatric Cushing's disease. Clin. Endocrinol. (Oxf.) 62 (2005) 466-472
89. Carroll P.V., et al. Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion. Clin. Endocrinol. (Oxf.) 60 (2004) 169-174
90. Leong G.M., et al. Effects of child- and adolescent-onset endogenous Cushing syndrome on bone mass, body composition and growth: a 7-year prospective study into young adulthood. J. Bone Miner. Res. 22 (2007) 110-118
91. Scommegna S., et al. Bone mineral density at diagnosis and following successful treatment of disease. J. Endocrinol. Invest. 28 (2005) 231-235